Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases.
Italia
Khushnooma Y
KY
National Institute of Immunohaematology, Parel, Mumbai 400 012, India.
Jijina
Farah F
FF
Chandrakala
S
S
Nadkarni
Anita H
AH
Sawant
Pratibha
P
Ghosh
Kanjaksha
K
Colah
Roshan B
RB
D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000503:physiopathology; D000986:Antisickling Agents / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology* / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome; D017086:beta-Thalassemia / Q000188:drug therapy* / Q000503:physiopathology
D000986:Antisickling Agents; D006918:Hydroxyurea